The present invention discloses novel molecules consisting of N-methyl-D-aspartate
receptor (NMDAR) antagonists-
polymer conjugates having a general structure D-(X-Poly-T)n, wherein D is an high affinity, i.e., (+)-, (−)-, or (±)-dizocilpine, or a
low affinity, i.e., (+)-, (−)-, or (±)-
methadone, CNS active NMDAR
antagonist, n is an integer comprised between 1 and 6. X is a stable (enzymatically and / or hydrolytically under physiological conditions)
linker comprising a
covalent bond or a chain of atoms that covalently attaches a
small molecule NMDAR
antagonist drug moiety to the Poly derivative. Poly is a covalently bonded chain of repeating
monomer units that form a
polymer or an
oligomer backbone of synthetic or natural origin. T, if present, is either another molecule of D, or a terminal group of Poly, represented by any suitable chemical group which, depending upon preference, is unreactive or reactive with other chemical moieties, or has a targeting property.